PALO ALTO, Calif. and VANCOUVER, British Columbia, Dec. 19, 2016 /PRNewswire/ -- Angiotech Pharmaceuticals (Canada) today announced that it has entered into a definitive agreement to be acquired by a group of investors led by Vivo Capital LLC, a leading healthcare focused investment firm,...